E. Berglin

发表

Anti-carbamylated protein antibodies in the pre-symptomatic phase of rheumatoid arthritis, their relationship with multiple anti-citrulline peptide antibodies and association with radiological damage

R. Toes, S. Rantapää-Dahlqvist, L. Klareskog, 2015, Arthritis Research & Therapy.

Anti-neutrophil cytoplasmic antibodies predate symptom onset of ANCA-associated vasculitis. A case-control study.

S. Rantapää-Dahlqvist, L. Johansson, C. Eriksson, 2020, Journal of autoimmunity.

Comparison of the 1987 ACR and 2010 ACR/EULAR classification criteria for rheumatoid arthritis in clinical practice: a prospective cohort study

S. Dahlqvist, E. Berglin, 2013, Scandinavian journal of rheumatology.

A combination of autoantibodies to cyclic citrullinated peptide (CCP) and HLA-DRB1 locus antigens is strongly associated with future onset of rheumatoid arthritis

G. Hallmans, L. Padyukov, L. Klareskog, 2004, Arthritis research & therapy.

Oral Microbiota Profile in Patients with Anti-Neutrophil Cytoplasmic Antibody–Associated Vasculitis

S. Rantapää-Dahlqvist, I. Johansson, A. Esberg, 2022, Microorganisms.

Anti-neutrophil cytoplasmic antibodies predate symptom onset of ANCA-associated vasculitis. A case-control study Journal of Autoimmunity

S. Rantapää-Dahlqvist, L. Johansson, C. Eriksson, 2021 .

Identification and functional characterization of a novel susceptibility locus for small vessel vasculitis with MPO-ANCA

K. Lindblad-Toh, R. Jonsson, Diana Ekman, 2021, Rheumatology.

Association between age at disease onset of anti-neutrophil cytoplasmic antibody-associated vasculitis and clinical presentation and short-term outcomes.

D. T. Gray, Janet A. Blood, I. Bruce, 2020, Rheumatology.

A genetic study on C5-TRAF1 and progression of joint damage in rheumatoid arthritis

P. Gregersen, A. Zhernakova, T. Huizinga, 2015, Arthritis Research & Therapy.

Antibodies of IgG, IgA and IgM isotypes against cyclic citrullinated peptide precede the development of rheumatoid arthritis

Göran Hallmans, G. Hallmans, S. Rantapää-Dahlqvist, 2011, Arthritis research & therapy.

Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis.

Göran Hallmans, Hans Stenlund, G. Hallmans, 2003, Arthritis and rheumatism.

Studies on ageing and the severity of radiographic joint damage in rheumatoid arthritis

P. Gregersen, D. M. van der Heijde, M. Reijnierse, 2015, Arthritis Research & Therapy.

Decrease in bone mineral density during three months after diagnosis of early rheumatoid arthritis measured by digital X-ray radiogrammetry predicts radiographic joint damage after one year

K. Riklund, T. Skogh, A. Kastbom, 2017, Arthritis Research & Therapy.

Antibodies against mutated citrullinated vimentin are a better predictor of disease activity at 24 months in early rheumatoid arthritis than antibodies against cyclic citrullinated peptides.

H. Kokkonen, C. Eriksson, E. Berglin, 2008, The Journal of rheumatology.

Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset

G. Hallmans, S. Rantapää-Dahlqvist, G. Wadell, 2005, Annals of the rheumatic diseases.

Predictors of disease onset and progression in early rheumatoid arthritis : A clinical, laboratory and radiological study

E. Berglin, 2006 .

Anti-cyclic citrullinated peptide antibodies are associated with radiographic damage but not disease activity in early rheumatoid arthritis diagnosed in 2006–2011

I. Thyberg, S. Rantapää-Dahlqvist, T. Skogh, 2020, Scandinavian journal of rheumatology.

12 Association of Valine and Leucine at HLA-DRB1 position 11 with radiographic progression in rheumatoid arthritis, independent of the shared epitope alleles but not independent of anti-citrullinated peptide antibodies

S. Raychaudhuri, T. Huizinga, L. Rodríguez-Rodríguez, 2016 .

Antibodies against citrullinated peptides are associated with clinical and radiological outcomes in patients with early rheumatoid arthritis: a prospective longitudinal inception cohort study

S. Rantapää-Dahlqvist, L. Klareskog, R. Holmdahl, 2019, RMD Open.

Receptor activator of nuclear factor kappa-B ligand (RANKL) but not sclerostin or gene polymorphisms is related to joint destruction in early rheumatoid arthritis

S. Rantapää-Dahlqvist, L. Ärlestig, H. Kokkonen, 2017, Clinical Rheumatology.

Hormonal and Reproductive Factors in Relation to Cardiovascular Events in Women with Early Rheumatoid Arthritis

S. Rantapää-Dahlqvist, H. Kokkonen, E. Berglin, 2022, Journal of clinical medicine.

A genetic study on C 5-TRAF 1 and progression of joint damage in rheumatoid arthritis

P. Gregersen, A. Zhernakova, T. Huizinga, 2015 .

Age at onset determines severity and choice of treatment in early rheumatoid arthritis: a prospective study

S. Rantapää-Dahlqvist, S. Wållberg-Jonsson, E. Berglin, 2014, Arthritis Research & Therapy.

Life satisfaction in early rheumatoid arthritis: A prospective study

S. Wållberg-Jonsson, E. Berglin, B. Karlsson, 2006, Scandinavian journal of occupational therapy.

Influence of female hormonal factors, in relation to autoantibodies and genetic markers, on the development of rheumatoid arthritis in northern Sweden: a case–control study

Å. Ågren, E. Einarsdottir, H. Kokkonen, 2010, Scandinavian journal of rheumatology.

Predictors of radiological progression and changes in hand bone density in early rheumatoid arthritis.

R. Lorentzon, R Lorentzon, S. Rantapää Dahlqvist, 2003, Rheumatology.

Protein Profiling in Presymptomatic Individuals Separates Myeloperoxidase–Antineutrophil Cytoplasmic Antibody and Proteinase 3–Antineutrophil Cytoplasmic Antibody Vasculitides

A. Alexeyenko, S. Rantapää-Dahlqvist, A. Lundquist, 2023 .

Complement activation prior to symptom onset in myeloperoxidase ANCA-associated vasculitis but not proteinase 3 ANCA associated vasculitis - A Swedish biobank study

S. Rantapää-Dahlqvist, J. Dahlqvist, E. Berglin, 2022, Scandinavian journal of rheumatology.

Antibodies against cyclic citrullinated peptide (CCP) in psoriatic patients with or without joint inflammation

S. Rantapää Dahlqvist, S. Dahlqvist, E. Berglin, 2005, Annals of the rheumatic diseases.

Conversion towards an atherogenic lipid profile in rheumatoid arthritis patients during long‐term infliximab therapy

O. Johnson, S. Dahlqvist, E. Berglin, 2006, Scandinavian journal of rheumatology.

Extent of atherosclerosis after 11-year prospective follow-up in patients with early rheumatoid arthritis was affected by disease severity at diagnosis

S. Rantapää-Dahlqvist, E. Berglin, E. Berglin, 2020, Scandinavian journal of rheumatology.

Incidence and predisposing factors of extra-articular manifestations in contemporary rheumatoid arthritis.

S. Rantapää-Dahlqvist, E. Berglin, Elias Jönsson, 2024, European journal of internal medicine.

Does a Genetic Variant in FOXO3A Predict a Milder Course of Rheumatoid Arthritis?

P. Gregersen, S. Rantapää-Dahlqvist, T. Huizinga, 2014, Arthritis & rheumatology.

Comparison of the 1987 ACR and 2010 ACR/EULAR classification criteria for rheumatoid arthritis in clinical practice: a prospective cohort study

E. Berglin, S. R. Dahlqvist, 2013, Scandinavian journal of rheumatology.

The HLA region in ANCA-associated vasculitis: characterisation of genetic associations in a Scandinavian patient population

S. Rantapää-Dahlqvist, J. Meadows, S. Ohlsson, 2024, RMD open.

Original article Identification and functional characterization of a novel susceptibility locus for small vessel vasculitis with MPO-ANCA

K. Lindblad-Toh, B. Sennblad, J. Meadows, 2022 .

Stratified genetic analysis reveals sex differences in MPO-ANCA-associated vasculitis

K. Lindblad-Toh, R. Jonsson, Diana Ekman, 2023, Rheumatology.